digoxin
地高辛
常用释义
英音[ ˌdɪˈdʒɒksɪn ]
美音[ ˌdɪˈdʒɑːksɪn ]
基本释义
- n. [药] 地高辛；[药] 异羟基洋地黄毒苷原
例句
-
1·According to the experimental results dosage of digoxin for children was discussed.根据各组实验结果分析讨论，并对小儿应用狄戈辛的剂量提出建议。
-
2·Methods Statistical analysis was conducted on Digoxin control data determined together with the patient samples of 2007 and 2008.方法对2007年及2008年的血药浓度监测中随行质控样本测定值进行统计学分析。
-
3·Objective to discuss the importance of blood concentration monitoring in more individualized and rationalized administration of Digoxin.目的：探讨血药浓度监测对个体化、合理化用药的重要作用。
-
4·The cause of death was concluded to be severe hypotension, bradycardia and cardiac failure due to combined intoxication with verapamil, metoprolol and digoxin.死亡原因是维拉·帕米、美多心安和地高辛联合中毒引起的严重低血压、心动过缓和心脏衰竭。
-
5·METHODS: It was observed that different concentration of anti-digoxin antiserum effect on endoxin and cell membrane ATPase activity in hypoxic myocardium model.方法： 制备心肌组织缺氧模型，观察不同剂量的地高辛抗血清对缺氧损伤心肌组织内洋地黄素水平和心肌细胞膜ATP酶活性的影响。
-
6·OBJECTIVE: to develop the data processing program of Digoxin blood drug concentration (DBDP) and to determine the range of effective blood concentration of Digoxin.目的：开发地高辛血药浓度数据处理(DBDP)程序，确定地高辛有效血药浓度范围。
-
7·Objective: To evaluate the effect and safety of combination of digoxin and sotalol for control of the ventricular response in patients with sustained atrial fibrillation.目的：评估联合应用索他洛尔与地高辛控制持续性心房颤动(房颤)心室率的疗效和安全性。
-
8·Method: the digoxin blood concentration was monitored by fluorescence polarizing immunization, the influence factors, such as age, disease, and combined with drug, were analysed.方法：使用荧光偏振免疫法监测地高辛血浓度，并统计分析年龄、疾病、合并用药等因素对地高辛血浓度的影响。
-
9·Objective: To study on the plasma level of at rial natriuretic polypeptide (ANP) and effect of digoxin in the rats with chronic congestive heart failure (CHF) by pressure overload.目的：观察后负荷增加所致充血性心力衰竭(CHF)大鼠血浆心钠素(ANP)水平的变化及地高辛的影响。
-
10·In patients taking digoxin in recommended doses, digoxin toxicity can occur in the setting of hypokalemia or hypomagnesemia, even though the serum digoxin level is within normal limits.服用推荐剂量的地高辛患者，即使血清地高辛浓度在正常范围内，地高辛中毒也可在低钾血症或低镁血症情况下发生。